Dexamethasone versus standard treatment for postoperative nausea and vomiting in gastrointestinal surgery: randomised controlled trial (DREAMS Trial)

DREAMS Trial Collaborators and West Midlands Research Collaborative, DREAMS Trial Collaborators and West Midlands Research Collaborative

Abstract

Objectives To determine whether preoperative dexamethasone reduces postoperative vomiting in patients undergoing elective bowel surgery and whether it is associated with other measurable benefits during recovery from surgery, including quicker return to oral diet and reduced length of stay.Design Pragmatic two arm parallel group randomised trial with blinded postoperative care and outcome assessment.Setting 45 UK hospitals.Participants 1350 patients aged 18 or over undergoing elective open or laparoscopic bowel surgery for malignant or benign pathology.Interventions Addition of a single dose of 8 mg intravenous dexamethasone at induction of anaesthesia compared with standard care.Main outcome measures Primary outcome: reported vomiting within 24 hours reported by patient or clinician.

Secondary outcomes: vomiting with 72 and 120 hours reported by patient or clinician; use of antiemetics and postoperative nausea and vomiting at 24, 72, and 120 hours rated by patient; fatigue and quality of life at 120 hours or discharge and at 30 days; time to return to fluid and food intake; length of hospital stay; adverse events.Results 1350 participants were recruited and randomly allocated to additional dexamethasone (n=674) or standard care (n=676) at induction of anaesthesia. Vomiting within 24 hours of surgery occurred in 172 (25.5%) participants in the dexamethasone arm and 223 (33.0%) allocated standard care (number needed to treat (NNT) 13, 95% confidence interval 5 to 22; P=0.003). Additional postoperative antiemetics were given (on demand) to 265 (39.3%) participants allocated dexamethasone and 351 (51.9%) allocated standard care (NNT 8, 5 to 11; P<0.001). Reduction in on demand antiemetics remained up to 72 hours. There was no increase in complications.Conclusions Addition of a single dose of 8 mg intravenous dexamethasone at induction of anaesthesia significantly reduces both the incidence of postoperative nausea and vomiting at 24 hours and the need for rescue antiemetics for up to 72 hours in patients undergoing large and small bowel surgery, with no increase in adverse events.Trial registration EudraCT (2010-022894-32) and ISRCTN (ISRCTN21973627).

Conflict of interest statement

Competing interests: All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf and declare: no support from any organisation for the submitted work beyond the study grants listed above; no financial relationships with any organisations that might have an interest in the submitted work in the previous three years; no other relationships or activities that could appear to have influenced the submitted work.

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.

Figures

https://www.ncbi.nlm.nih.gov/pmc/articles/instance/5482348/bin/magl035972.f1.jpg
Fig 1 Flow of patients undergoing gastrointestinal surgery through trial of dexamethasone versus standard treatment for postoperative nausea and vomiting
https://www.ncbi.nlm.nih.gov/pmc/articles/instance/5482348/bin/magl035972.f2.jpg
Fig 2 Frequency of vomiting and use of antiemetics. Primary outcome is comparison of vomiting in 0-24 hours
https://www.ncbi.nlm.nih.gov/pmc/articles/instance/5482348/bin/magl035972.f3.jpg
Fig 3 Reduction in vomiting after gastrointestinal surgery within 24 hours (primary outcome) by subgroups according to allocation to preoperative dexamethasone or standard care

References

    1. Gan TJ. Postoperative nausea and vomiting--can it be eliminated?JAMA 2002;287:1233-6. 10.1001/jama.287.10.1233 .
    1. Cohen MM, Duncan PG, DeBoer DP, Tweed WA. The postoperative interview: assessing risk factors for nausea and vomiting. Anesth Analg 1994;78:7-16. 10.1213/00000539-199401000-00004 .
    1. Macario A, Weinger M, Carney S, Kim A. Which clinical anesthesia outcomes are important to avoid? The perspective of patients. Anesth Analg 1999;89:652-8..
    1. Apfel CC, Heidrich FM, Jukar-Rao S, et al. Evidence-based analysis of risk factors for postoperative nausea and vomiting. Br J Anaesth 2012;109:742-53. 10.1093/bja/aes276 .
    1. Ehrlich A, Wagner B, Kairaluoma M, Mecklin JP, Kautiainen H, Kellokumpu I. Evaluation of a fast-track protocol for patients undergoing colorectal surgery. Scand J Surg 2014;103:182-8. 10.1177/1457496913516295 .
    1. Russell CA, Elia M. Nutrition screening survey in the uk in 2008. BAPEN 2009.
    1. Ho KM, Tan JA. Benefits and risks of corticosteroid prophylaxis in adult cardiac surgery: a dose-response meta-analysis. Circulation 2009;119:1853-66. 10.1161/CIRCULATIONAHA.108.848218 .
    1. Chaney MA. Corticosteroids and cardiopulmonary bypass : a review of clinical investigations. Chest 2002;121:921-31. 10.1378/chest.121.3.921 .
    1. Apfel CC, Korttila K, Abdalla M, et al. IMPACT Investigators. A factorial trial of six interventions for the prevention of postoperative nausea and vomiting. N Engl J Med 2004;350:2441-51. 10.1056/NEJMoa032196 .
    1. Gan TJ, Diemunsch P, Habib AS, et al. Society for Ambulatory Anesthesia. Consensus guidelines for the management of postoperative nausea and vomiting. Anesth Analg 2014;118:85-113. 10.1213/ANE.0000000000000002 .
    1. Kehlet H, Wilmore DW. Evidence-based surgical care and the evolution of fast-track surgery. Ann Surg 2008;248:189-98. 10.1097/SLA.0b013e31817f2c1a .
    1. Kehlet H, Dahl JB. Anaesthesia, surgery, and challenges in postoperative recovery. Lancet 2003;362:1921-8. 10.1016/S0140-6736(03)14966-5 .
    1. Fearon KC, Ljungqvist O, Von Meyenfeldt M, et al. Enhanced recovery after surgery: a consensus review of clinical care for patients undergoing colonic resection. Clin Nutr 2005;24:466-77. 10.1016/j.clnu.2005.02.002 .
    1. Kirdak T, Yilmazlar A, Cavun S, Ercan I, Yilmazlar T. Does single, low-dose preoperative dexamethasone improve outcomes after colorectal surgery based on an enhanced recovery protocol? Double-blind, randomized clinical trial. Am Surg 2008;74:160-7..
    1. Zargar-Shoshtari K, Sammour T, Kahokehr A, Connolly AB, Hill AG. Randomized clinical trial of the effect of glucocorticoids on peritoneal inflammation and postoperative recovery after colectomy. Br J Surg 2009;96:1253-61. 10.1002/bjs.6744 .
    1. Sauerland S, Nagelschmidt M, Mallmann P, Neugebauer EA. Risks and benefits of preoperative high dose methylprednisolone in surgical patients: a systematic review. Drug Saf 2000;23:449-61. 10.2165/00002018-200023050-00007 .
    1. Wang JJ, Ho ST, Tzeng JI, Tang CS. The effect of timing of dexamethasone administration on its efficacy as a prophylactic antiemetic for postoperative nausea and vomiting. Anesth Analg 2000;91:136-9..
    1. Zou Z, Jiang Y, Xiao M, Zhou R. The impact of prophylactic dexamethasone on nausea and vomiting after thyroidectomy: a systematic review and meta-analysis. PLoS One 2014;9:e109582 10.1371/journal.pone.0109582 .
    1. Ryu JH, Chang JE, Kim HR, Hwang JW, Oh AY, Do SH. Ramosetron vs. ramosetron plus dexamethasone for the prevention of postoperative nausea and vomiting (PONV) after laparoscopic cholecystectomy: prospective, randomized, and double-blind study. Int J Surg 2013;11:183-7. 10.1016/j.ijsu.2012.12.018 .
    1. Wengritzky R, Mettho T, Myles PS, Burke J, Kakos A. Development and validation of a postoperative nausea and vomiting intensity scale. Br J Anaesth 2010;104:158-66. 10.1093/bja/aep370 .
    1. Webster K, Cella D, Yost K. The Functional Assessment of Chronic Illness Therapy (FACIT) Measurement System: properties, applications, and interpretation. Health Qual Life Outcomes 2003;1:79 10.1186/1477-7525-1-79 .
    1. EuroQol Group. EuroQol--a new facility for the measurement of health-related quality of life. Health Policy 1990;16:199-208. 10.1016/0168-8510(90)90421-9 .
    1. Brooks R. EuroQol: the current state of play. Health Policy 1996;37:53-72. 10.1016/0168-8510(96)00822-6 .
    1. Apfel CC, Kranke P, Eberhart LH, Roos A, Roewer N. Comparison of predictive models for postoperative nausea and vomiting. Br J Anaesth 2002;88:234-40. 10.1093/bja/88.2.234 .
    1. Ho CM, Wu HL, Ho ST, Wang JJ. Dexamethasone prevents postoperative nausea and vomiting: benefit versus risk. Acta Anaesthesiol Taiwan 2011;49:100-4. 10.1016/j.aat.2011.06.002 .
    1. Holte K, Kehlet H. Perioperative single-dose glucocorticoid administration: pathophysiologic effects and clinical implications. J Am Coll Surg 2002;195:694-712. 10.1016/S1072-7515(02)01491-6 .
    1. Murphy GS, Sherwani SS, Szokol JW, et al. Small-dose dexamethasone improves quality of recovery scores after elective cardiac surgery: a randomized, double-blind, placebo-controlled study. J Cardiothorac Vasc Anesth 2011;25:950-60. 10.1053/j.jvca.2011.03.002 .
    1. Liu K, Hsu CC, Chia YY. The effective dose of dexamethasone for antiemesis after major gynecological surgery. Anesth Analg 1999;89:1316-8. 10.1213/00000539-199911000-00046 .
    1. Wang JJ, Ho ST, Lee SC, Liu YC, Ho CM. The use of dexamethasone for preventing postoperative nausea and vomiting in females undergoing thyroidectomy: a dose-ranging study. Anesth Analg 2000;91:1404-7. 10.1097/00000539-200012000-00019 .
    1. Karanicolas PJ, Smith SE, Kanbur B, Davies E, Guyatt GH. The impact of prophylactic dexamethasone on nausea and vomiting after laparoscopic cholecystectomy: a systematic review and meta-analysis. Ann Surg 2008;248:751-62. 10.1097/SLA.0b013e3181856024 .
    1. Elhakim M, Nafie M, Mahmoud K, Atef A. Dexamethasone 8 mg in combination with ondansetron 4 mg appears to be the optimal dose for the prevention of nausea and vomiting after laparoscopic cholecystectomy. Can J Anaesth 2002;49:922-6. 10.1007/BF03016875 .
    1. Henzi I, Walder B, Tramèr MR. Dexamethasone for the prevention of postoperative nausea and vomiting: a quantitative systematic review. Anesth Analg 2000;90:186-94. 10.1097/00000539-200001000-00038 .
    1. Waldron NH, Jones CA, Gan TJ, Allen TK, Habib AS. Impact of perioperative dexamethasone on postoperative analgesia and side-effects: systematic review and meta-analysis. Br J Anaesth 2013;110:191-200. 10.1093/bja/aes431 .
    1. Nazar CE, Lacassie HJ, López RA, Muñoz HR. Dexamethasone for postoperative nausea and vomiting prophylaxis: effect on glycaemia in obese patients with impaired glucose tolerance. Eur J Anaesthesiol 2009;26:318-21. 10.1097/EJA.0b013e328319c09b .
    1. Hans P, Vanthuyne A, Dewandre PY, Brichant JF, Bonhomme V. Blood glucose concentration profile after 10 mg dexamethasone in non-diabetic and type 2 diabetic patients undergoing abdominal surgery. Br J Anaesth 2006;97:164-70. 10.1093/bja/ael111 .
    1. Gan TJ, Meyer TA, Apfel CC, et al. Society for Ambulatory Anesthesia. Society for Ambulatory Anesthesia guidelines for the management of postoperative nausea and vomiting[table of contents.] Anesth Analg 2007;105:1615-28. 10.1213/01.ane.0000295230.55439.f4 .
    1. Hamilton E, Ravikumar R, Bartlett D, et al. West Midlands Research Collaborative. Dexamethasone reduces emesis after major gastrointestinal surgery (DREAMS). Trials 2013;14:249 10.1186/1745-6215-14-249 .

Source: PubMed

스폰서 및 공동 작업자

건강 상태

약물 개입

3
구독하다